Evidence map›Paper›PMID 26295053›Full record

ArticleBioMed research international2015

Association of Environmental Arsenic Exposure, Genetic Polymorphisms of Susceptible Genes, and Skin Cancers in Taiwan.

Ling-I Hsu, Meei-Maan Wu, Yuan-Hung Wang, Cheng-Yeh Lee, Tse-Yen Yang, Bo-Yu Hsiao, Chien-Jen Chen

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Effects of arsenic toxicity beyond epigenetic modifications.Environmental geochemistry and health · 2018
    Review
  12. Article
  13. Article
  14. Molecular insight of arsenic-induced carcinogenesis and its prevention.Naunyn-Schmiedeberg's archives of pharmacology · 2017
    Review
  15. Article
  16. Article
  17. Endocrine-disrupting chemicals and skin manifestations.Reviews in endocrine & metabolic disorders · 2016
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Ling-I HsuGenomics Research Center, Academia Sinica, No. 128 Academia Road, Section 2, Nankang, Taipei 115, Taiwan.
Meei-Maan WuGraduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei 100, Taiwan ; School of Public Health, College of Public Health and Nutrition, Taipei Medical University, 250 Wu-Hsing Street, Taipei 110, Taiwan.
Yuan-Hung WangDepartment of Medical Research, Shuang Ho Hospital, Taipei Medical University, No. 291 Zhongzheng Road, Zhonghe District, New Taipei City 23561, Taiwan ; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, 250 Wu-Hsing Street, Taipei 110, Taiwan.
Cheng-Yeh LeeGenomics Research Center, Academia Sinica, No. 128 Academia Road, Section 2, Nankang, Taipei 115, Taiwan.
Tse-Yen YangMolecular and Genomic Epidemiology Center, China Medical University Hospital, China Medical University, Taichung 404, Taiwan.
Bo-Yu HsiaoGenomics Research Center, Academia Sinica, No. 128 Academia Road, Section 2, Nankang, Taipei 115, Taiwan.
Chien-Jen ChenGenomics Research Center, Academia Sinica, No. 128 Academia Road, Section 2, Nankang, Taipei 115, Taiwan ; Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, 17 Xu-Zhou Road, Taipei 100, Taiwan.
Genomics Research Center, Academia Sinica · TWNational Taiwan University · TWChina Medical University · TWTaipei Medical University-Shuang Ho Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deficiency in the capability of xenobiotic detoxification and arsenic methylation may be correlated with individual susceptibility to arsenic-related skin cancers. We hypothesized that glutathione S-transferase (GST M1, T1, and P1), reactive oxygen species (ROS) related metabolic genes (NQO1, EPHX1, and HO-1), and DNA repair genes (XRCC1, XPD, hOGG1, and ATM) together may play a role in arsenic-induced skin carcinogenesis. We conducted a case-control study consisting of 70 pathologically confirmed skin cancer patients and 210 age and gender matched participants with genotyping of 12 selected polymorphisms. The skin cancer risks were estimated by odds ratio (OR) and 95% confidence interval (CI) using logistic regression. EPHX1 Tyr113His, XPD C156A, and GSTT1 null genotypes were associated with skin cancer risk (OR = 2.99, 95% CI = 1.01-8.83; OR = 2.04, 95% CI = 0.99-4.27; OR = 1.74, 95% CI = 1.00-3.02, resp.). However, none of these polymorphisms showed significant association after considering arsenic exposure status. Individuals carrying three risk polymorphisms of EPHX1 Tyr113His, XPD C156A, and GSTs presented a 400% increased skin cancer risk when compared to those with less than or equal to one polymorphism. In conclusion, GSTs, EPHX1, and XPD are potential genetic factors for arsenic-induced skin cancers. The roles of these genes for arsenic-induced skin carcinogenesis need to be further evaluated.

Indexed as

AgedArsenicEnvironmental ExposureEpoxide HydrolasesFemaleGenetic Association StudiesGenotypeGlutathione TransferaseHumansMaleMiddle AgedPolymorphism, Single NucleotideRisk FactorsSkin NeoplasmsTaiwanXeroderma Pigmentosum Group D ProteinArsenicEPHX1 protein, humanEpoxide HydrolasesERCC2 protein, humanGlutathione TransferaseXeroderma Pigmentosum Group D Protein

Identifiers

PMID26295053
PMCPMC4532812
OpenAlexW1588556506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.